High-resolution mapping of prostaglandin E2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8+CD45RO+ T cells.

To analyze prostaglandin E(2) (PGE(2)) signaling in lymphoid cells, we introduce a multipronged strategy, combining temporal quantitative phosphoproteomics and phospho flow cytometry. We describe the PGE(2)-induced phosphoproteome by simultaneous monitoring of approximately 250 regulated phospho-epitopes, which, according to kinase prediction algorithms, originate from a limited number of kinase networks. Assessing these signaling pathways by phospho flow cytometry provided higher temporal resolution at various PGE(2) concentrations in multiple lymphoid cell subsets. This showed elevated levels of protein kinase A (PKA) signaling in unstimulated CD8(+)CD45RO(+) T cells, which correlated with suppressed proximal T-cell receptor signaling, indicating that PKA sets the threshold for activation. The combination of phosphoproteomics and high throughput phospho flow cytometry applied here provides a comprehensive generic framework for the analysis of signaling networks in mixed cell populations.

[1]  P. Sorger,et al.  Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.

[2]  Reinout Raijmakers,et al.  Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics , 2009, Nature Protocols.

[3]  Albert J R Heck,et al.  Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates , 2008, Proteomics.

[4]  S. Lemeer,et al.  Comparative Phosphoproteomics of Zebrafish Fyn/Yes Morpholino Knockdown Embryos*S , 2008, Molecular & Cellular Proteomics.

[5]  S. Lemeer,et al.  Online automated in vivo zebrafish phosphoproteomics: from large-scale analysis down to a single embryo. , 2008, Journal of proteome research.

[6]  Joost W Gouw,et al.  Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster. , 2008, Journal of proteome research.

[7]  Tony Pawson,et al.  NetworKIN: a resource for exploring cellular phosphorylation networks , 2007, Nucleic Acids Res..

[8]  K. Torgersen,et al.  Molecular architecture of signal complexes regulating immune cell function. , 2008, Handbook of experimental pharmacology.

[9]  E. Aandahl,et al.  Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner , 2008, Cancer Immunology, Immunotherapy.

[10]  M. Mann,et al.  PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites , 2007, Genome Biology.

[11]  S. Narumiya,et al.  Prostaglandin Receptor Signaling in Disease , 2007, TheScientificWorldJournal.

[12]  P. Bork,et al.  Systematic Discovery of In Vivo Phosphorylation Networks , 2007, Cell.

[13]  M. Conti,et al.  Differential Expression and Function of Phosphodiesterase 4 (PDE4) Subtypes in Human Primary CD4+ T Cells: Predominant Role of PDE4D1 , 2007, The Journal of Immunology.

[14]  S. Mathivanan,et al.  A curated compendium of phosphorylation motifs , 2007, Nature Biotechnology.

[15]  M. Conti,et al.  Differential Expression and Function of Phosphodiesterase 4 (PDE4) Subtypes in Human Primary CD4 T Cells: Predominant Role of PDE4D , 2007 .

[16]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[17]  E. Aandahl,et al.  FOXP3+CD4+CD25+ Adaptive Regulatory T Cells Express Cyclooxygenase-2 and Suppress Effector T Cells by a Prostaglandin E2-Dependent Mechanism1 , 2006, The Journal of Immunology.

[18]  E. Aandahl,et al.  The Cyclic AMP-Epac1-Rap1 Pathway Is Dissociated from Regulation of Effector Functions in Monocytes but Acquires Immunoregulatory Function in Mature Macrophages1 , 2006, The Journal of Immunology.

[19]  Garry P Nolan,et al.  Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling , 2006, Nature Methods.

[20]  E. Bjørgo,et al.  Role of cAMP phosphodiesterase 4 in regulation of T-cell function. , 2006, Critical reviews in immunology.

[21]  M. Mann,et al.  Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.

[22]  Jeroen Krijgsveld,et al.  Mass spectrometry-based quantitative proteomics , 2004, Expert review of proteomics.

[23]  D. Farber,et al.  Signaling control of memory T cell generation and function. , 2004, Seminars in immunology.

[24]  F. Regnier,et al.  Quantification in proteomics through stable isotope coding: a review. , 2004, Journal of proteome research.

[25]  J. Loureiro,et al.  Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. , 2003, Annual review of cell and developmental biology.

[26]  Michael B. Yaffe,et al.  Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs , 2003, Nucleic Acids Res..

[27]  K. Taskén,et al.  Combined Spatial and Enzymatic Regulation of Csk by cAMP and Protein Kinase A Inhibits T Cell Receptor Signaling* , 2003, The Journal of Biological Chemistry.

[28]  L. Audoly,et al.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. , 2002, The Journal of clinical investigation.

[29]  C. Allis,et al.  Involvement of Histone Methylation and Phosphorylation in Regulation of Transcription by Thyroid Hormone Receptor , 2002, Molecular and Cellular Biology.

[30]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[31]  J. Shabb.  Physiological substrates of cAMP-dependent protein kinase. , 2001, Chemical reviews.

[32]  J. Woodgett,et al.  Glycogen synthase kinase-3: properties, functions, and regulation. , 2001, Chemical reviews.

[33]  Tomas Mustelin,et al.  Activation of the Cooh-Terminal Src Kinase (Csk) by Camp-Dependent Protein Kinase Inhibits Signaling through the T Cell Receptor , 2001, The Journal of experimental medicine.

[34]  H. S. Kim,et al.  The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. , 2001, The Journal of clinical investigation.

[35]  R. Breyer,et al.  Prostanoid receptors: subtypes and signaling. , 2001, Annual review of pharmacology and toxicology.

[36]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[37]  R. DuBois,et al.  Aspirin use and potential mechanisms for colorectal cancer prevention. , 1997, The Journal of clinical investigation.

[38]  S. Narumiya,et al.  Altered pain perception and inflammatory response in mice lacking prostacyclin receptor , 1997, Nature.

[39]  J. Brown,et al.  The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan. , 1997, Cancer research.

[40]  R. DuBois,et al.  Colorectal cancer and nonsteroidal anti-inflammatory drugs. , 1997, Advances in pharmacology.

[41]  M. Székely,et al.  Hypothalamic prostaglandin E2 during lipopolysaccharide-induced fever in guinea pigs , 1996, Brain Research Bulletin.

[42]  G. Thomas,et al.  Mitogenesis and protein synthesis: A role for ribosomal protein S6 phosphorylation? , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[43]  R. A. Coleman,et al.  Studies on the characterisation of prostanoid receptors: a proposed classification. , 1982, Prostaglandins.

[44]  D. Gordon,et al.  Is prostacyclin in the major pro-inflammatory prostanoid in joint fluid? , 1980, Life sciences.